Status:
UNKNOWN
Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)
Lead Sponsor:
GAAD Medical Research Institute Inc.
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Multiple sclerosis (abbreviated MS) is an autoimmune condition in which the immune system attacks the central nervous system (CNS), leading to demyelination. This study will investigate the use of far...
Detailed Description
MS a demyelinating disease, is any disease of the nervous system in which the myelin sheath of neurons is damaged. This impairs the conduction of signals in the affected nerves, causing impairment in ...
Eligibility Criteria
Inclusion
- Patients with MS
Exclusion
- None
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00674934
Start Date
May 1 2008
End Date
June 1 2010
Last Update
January 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Centre for Incurable Diseases
Toronto, Ontario, Canada, M4V 1L5